Nanobiotix
NANO | PA
Overview
Corporate Details
- ISIN(s):
- FR0010102145 (+2 more)
- LEI:
- 969500667RSYIH8YL895
- Country:
- France
- Address:
- 60 RUE DE WATTIGNIES, 75012 PARIS
- Website:
- https://www.nanobiotix.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Nanobiotix is a late-stage clinical biotechnology company pioneering the development and commercialization of physics-based nanotherapeutics for cancer treatment. Its lead product candidate, NBTXR3, is a potential first-in-class radioenhancer designed to be activated by radiotherapy. When injected directly into a tumor, NBTXR3 amplifies the cell-killing energy from radiation within the tumor, sparing surrounding healthy tissue. This approach aims to enhance the efficacy of radiotherapy for local tumor destruction and prime an immune response against metastases. The company is initially focused on treating solid tumors, particularly in head and neck and lung cancers. Nanobiotix has a global licensing agreement with Janssen Pharmaceutica NV, a Johnson & Johnson company, for the co-development and commercialization of NBTXR3.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Nanobiotix.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-02 22:15 |
ISS
Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright g…
|
French | 93.9 KB | |
| 2025-09-02 22:15 |
ISS
Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment …
|
English | 69.0 KB | |
| 2025-08-11 11:29 |
Major Shareholding Notification
Franchissements de seuils
|
French | 111.3 KB | |
| 2025-07-11 11:18 |
Major Shareholding Notification
Franchissement de seuils
|
French | 123.4 KB | |
| 2025-07-11 11:11 |
Major Shareholding Notification
Franchissement de seuils
|
French | 122.5 KB | |
| 2025-06-20 15:17 |
Major Shareholding Notification
Franchissement de seuils
|
French | 123.1 KB | |
| 2025-06-20 15:07 |
Major Shareholding Notification
Franchissement de seuils
|
French | 123.4 KB | |
| 2025-06-10 22:15 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total de droits de vote et d’actions c…
|
French | 110.8 KB | |
| 2025-06-10 22:15 |
Declaration of Voting Results & Voting Rights Announcements
Voting Rights and Shares Capital of the Company
|
English | 112.0 KB | |
| 2025-05-28 08:00 |
Regulatory News Service
NANOBIOTIX participera à la conférence investisseurs annuelle Jefferies Global …
|
French | 91.4 KB | |
| 2025-05-28 08:00 |
Regulatory News Service
NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference
|
English | 88.9 KB | |
| 2025-05-21 22:15 |
Regulatory News Service
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
|
English | 173.9 KB | |
| 2025-05-21 22:15 |
Earnings Release
Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du p…
|
French | 194.9 KB | |
| 2025-05-14 08:00 |
Declaration of Voting Results & Voting Rights Announcements
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS C…
|
French | 110.7 KB | |
| 2025-05-14 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Voting Rights and Shares Capital of the Company
|
English | 112.2 KB |
Automate Your Workflow. Get a real-time feed of all Nanobiotix filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Nanobiotix via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-11 | N/A | Other | Other | 959,060 | N/A |
